Dextera Surgical to Present at 7th Annual Craig-Hallum Alpha Select Conference
November 09 2016 - 8:00AM
Dextera Surgical Inc. (Nasdaq:DXTR), manufacturer of the
smallest-profile and most maneuverable articulating surgical
stapling platform on the market for minimally invasive surgery,
today announced that Julian Nikolchev, president and CEO, will
present a corporate update at the 7th Annual Craig-Hallum Alpha
Select Conference on November 16, 2016 at 1:30 p.m. Eastern Time.
To access the live and subsequently archived
webcast of the presentation, go to the Investor Relations section
of the company’s website at ir.dexterasurgical.com. Please connect
to the website at least 15 minutes prior to the presentation to
allow for any necessary software downloads.
About Dextera SurgicalDextera
Surgical (Nasdaq:DXTR) designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures. In the
U.S., surgical staplers are routinely used in more than one million
minimally invasive laparoscopic, video-assisted or robotic-assisted
surgical procedures annually.
The company's signature proprietary technology, the
MicroCutter 5/80 Stapler, is the world's first and only
five-millimeter surgical stapler that articulates to 80 degrees in
each direction. As the smallest-profile articulating stapler
available today, the MicroCutter 5/80 Stapler may reduce the amount
of dissection and tissue handling required to position the stapler
in confined spaces, enabling access to difficult-to-reach
anatomy. The cartridge-based device's small size and wide
articulation range are designed to enhance the surgeon's access and
visualization at the surgical site and to mitigate limitations on
the advancement of minimally invasive surgical approaches created
by larger stapling devices.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold by
Dextera Surgical under the Cardica brand name, have demonstrated
long-term reliable clinical performance for more than a decade.
Contact:
Investors:
Bob Newell
Vice President, Finance and Chief Financial Officer
+1 (650) 331-7133
investors@dexterasurgical.com
Media:
Jessica Volchok
+1 (310) 849-7985
jessica@nicoleosmer.com